Do COVID Treatments Need Better Media Coverage?
Jan. 12 2024
Awareness of Paxlovid, PAXCESS Assistance Program Could Be Aided By Journalists, Experts Say
Only 15% of high-risk COVID patients eligible for Paxlovid took it, an NIH study found. Four experts joined a National Press Foundation webinar to tackle awareness and access around antivirals.
‘Is My COVID Vaccine Covered?’ It Should Be.
Sept. 13 2023
The COVID Vaccine is Recommended by ACIP. Now What?
For updated COVID vaccine access, pharmacies will be where the “friction” is in the weeks ahead, doctor says.
Fauci on Monkeypox: ‘We Have a Problem Here’
July 01 2022
Dr. Anthony Fauci Says Not Enough Is Known About Monkeypox Or Long COVID
The U.S. doesn’t “have a handle” on monkeypox spread due to a lack of testing, Dr. Anthony Fauci said in a National Press Foundation exclusive briefing.
How Will Intellectual Property Affect COVID Inequity?
June 30 2022
The Debate Raises Questions of Ethics, Nationalism and Innovation
The WTO compromise on a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver has not settled the debate.
Reporting on Kids and the COVID Vaccine
Nov. 19 2021
Cutting Through Misinformation
Tips for reporters covering the coronavirus vaccine for children — and how it will impact families, schools and more.
Vaccine Passports: Ethics and Inequality
July 28 2021
Pro Tip: Call them “immunization credentials,” experts advise
Some experts call for U.S. digital credential to prove vaccine status, but others warn it could increase inequality and discrimination.
Two New Tools for Reporting on Vaccine Access and Information Needs
July 15 2021
They Might Not Tell Their Boss or Doctor, But People Confide in Google.
Google and public health officials have developed tools reporters can use to pinpoint “vaccine deserts” and communities where people are searching about vaccine side effects.
Vaccine Rollout: Progress and Challenges
March 03 2021
Public Health Experts Explain How the COVID-19 Vaccine Rollout Can Overcome Challenges, Hesitancy, Inequity
What’s the most effective way to get shots in the arms of a COVID-weary public? State and national public health officials explain their plans– and why they see the end of the COVID pandemic.
FDA Adviser: Time to Trust the Coronavirus Vaccine
Nov. 23 2020
FDA’s Emergency Approval Process Will Ensure Faster Access to Coronavirus Vaccine
A leading vaccine specialist says it’s time to put aside distrust in the process that should get a coronavirus vaccine to most Americans’ arms by spring.
The Ethics Behind Vaccine Trials
Oct. 23 2020
How Emergency Use Authorization, Human Challenge Affect COVID Vaccine
After seven months of restrictions, many are eager to develop and distribute COVID-19 vaccines quickly. But a top ethicist warns that sacrificing speed for safety might not be the best bet.
Tracking the Anti-Vaccination Movement
Oct. 19 2020
About a quarter of Americans say they wouldn't get a coronavirus vaccine.
Social media messaging urging U.S. citizens to reject vaccination has roughly tripled since the COVID-19 pandemic began and is now driving an increase in public suspicions of vaccines.
The Virus’ Long Timetable
Sept. 24 2020
Masking Up for the Long Haul: COVID-19 Won’t Go Away Quickly
The coronavirus isn’t going away anytime soon, meaning that Americans will need to remain masked up and socially distant until late 2021 – even with an approved vaccine, according to one of the nation’s top infectious disease specialists.
Vaccine Approval 101
Aug. 12 2020
FDA Vows to Maintain Standards for COVID Vaccine
Dr. Peter Marks, director of the FDA’s vaccines division, briefs NPF fellows on the hazards of expediting a coronavirus vaccine while also maintaining rigorous safety standards. Interactive transcript available.
The Path to a Coronavirus Vaccine
Aug. 12 2020
Novel Technologies on a Fast Track
While researchers and regulators are truncating some development steps, one thing experts say they can’t skimp on is 30,000-person safety and efficacy trials.
Building a Vaccine Infrastructure
Aug. 10 2020
From Lab to Doctor’s Office – the Challenges of Vaccinating 8 Billion People
Public health officials from local, national and international levels are preparing for a massive undertaking: Getting a coronavirus to everyone who needs it.
Vaccine Development 101
Aug. 06 2020
From ‘Whole Virus’ to ‘Replicating RNA’ Vaccines, a Scientist Explains the Basics
A University of Washington researcher explains the biology behind vaccine creation, including the RNA approach her team is developing.
The Effects of Vaccine Hesitancy
Aug. 04 2020
Coronavirus Vaccine Faces Early Battle Against Growing Pockets of Resistance
Despite successes in the lab and well-documented safety, vaccines face a growing number of skeptics. Will that imperil any coronavirus vaccine?
Ethics and the Coronavirus Vaccine
July 31 2020
Getting a Coronavirus Vaccine Is Only the First Step
A top ethicist warns that the vaccine will introduce thorny problems of safety, manufacturing, distribution — and deciding who should get it first.
The Race for a Coronavirus Vaccine
April 03 2020
A Leading Research Center Explains How Vaccines – Including for COVID-19 – are Created and Tested
Experts at the University of Maryland have long been involved in developing vaccines for emerging diseases. Now they are at work on one for coronavirus.
How to Write About Vaccine Deniers
Oct. 24 2019
Covering Vaccine Hesitancy
Researcher cautions reporters against “falsely balanced reporting” on vaccine hesitancy.
Developing Vaccines
Oct. 22 2019
Six Dimensions of Studying Emerging Infectious Diseases
At Institute Pasteur in Paris, researchers help develop new vaccines for emerging threats.
What’s Next in Vaccines
Aug. 02 2019
University of Maryland Center Studies New Vaccines Big Pharma Might Not
From malaria to emerging pathogens, center at the University of Maryland seeks to equalize health by pursuing new vaccines.
How Vaccines are Developed
July 31 2019
Technology is Advancing Vaccine Development
An industry researcher describes new technologies used to develop new vaccines.
Trust in Science and Vaccines
July 31 2019
In an Age of Big Advances, Why Is Public Sometimes Distrustful of Science?
Politics and science collide, leaving public skeptical of what scientists considered settled.
The FDA and Vaccines
July 30 2019
Federal Agency Role Ensuring Safety of Vaccines
FDA also works with industry to help spur vaccine development.
Wariness of Vaccines
July 30 2019
Vaccine Hesitancy is Increasing, Even as Science Improves
A childhood vaccination experts explains why some people skip widely recommended immunizations.
Politics and Vaccines
July 29 2019
How Can Something So Successful Be So Controversial?
Politics often colors the world of vaccines.
Who Decides Vaccine Guidelines?
July 29 2019
Understanding How Federal Officials Determine the Shots Every Child Receives
A longtime member of the federal vaccine recommendation committee details how the process works.
CDC’s Vaccine Surveillance
July 29 2019
Federal Efforts to Monitor and Respond to Infectious Diseases
A CDC official describes the efforts taken to help prevent disease outbreaks.
The Rationale for a TB Vaccine
Dec. 03 2015
13 Vaccines are in Clinical Trials Right Now
Vaccines wiped out polio and smallpox. Why is a TB vaccine so elusive?
1